Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates

被引:13
作者
Bessieres, Maxime [1 ]
Hervin, Vincent [1 ]
Roy, Vincent [1 ]
Chartier, Agnes [1 ]
Snoeck, Robert [2 ]
Andrei, Graciela [2 ]
Lohier, Jean-Francois [3 ]
Agrofoglio, Luigi A. [1 ]
机构
[1] Univ Orleans, CNRS, ICOA, UMR 7311, F-45067 Orleans, France
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Leuven, Belgium
[3] Univ Caen, CNRS, LCMT, UMR 6507, F-14050 Caen, France
关键词
Ultrasound; Aqueous cross-metathesis; Phosphonoamidate; Acyclic nucleoside phosphonates; DNA viruses; HUMAN-IMMUNODEFICIENCY-VIRUS; ARYLOXY PHOSPHORAMIDATE TRIESTERS; TENOFOVIR ALAFENAMIDE; PHOSPHONATE PRODRUGS; METATHESIS CATALYSTS; MEDICINAL CHEMISTRY; NUCLEOTIDE ANALOGS; OLEFIN METATHESIS; PHARMACOKINETICS; MICROWAVE;
D O I
10.1016/j.ejmech.2018.01.086
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several hitherto unknown (E)-but-2-enyl nucleoside phosphonoamidate analogs (ANPs) were prepared directed with nitrogen reagents by cross-metathesis in water-under ultrasound irradiation. Two diastereoisomers were formally identified by X-ray diffraction. These compounds were evaluated against a large spectrum of DNA and RNA viruses. Among them, the phosphonoamidate thymine analogue 19 emerged as the best prodrug against varicella-zoster virus (VZV) with EC50 values of 0.33 and 0.39 mu M for wild-type and thymidine kinase deficient strains, respectively, and a selectivity index >= 200 mu M. This breakthrough approach paves the way for new purine and pyrimidine (E)-but-2-enyl phosphonoamidate analogs. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:678 / 686
页数:9
相关论文
共 44 条
[1]   Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates [J].
Baszczynski, Ondrej ;
Janeba, Zlatko .
MEDICINAL RESEARCH REVIEWS, 2013, 33 (06) :1304-1344
[2]   Sonication-Assisted Synthesis of (E)-2-Methyl-but-2-enyl Nucleoside Phosphonate Prodrugs [J].
Bessieres, Maxime ;
Sari, Ozkan ;
Roy, Vincent ;
Warszycki, Dawid ;
Bojarski, Andrzej J. ;
Nolan, Steven P. ;
Snoeck, Robert ;
Andrei, Graciela ;
Schinazi, Raymond F. ;
Agrofoglio, Luigi A. .
CHEMISTRYSELECT, 2016, 1 (12) :3108-3113
[3]   A convenient, highly selective and eco-friendly N-Boc protection of pyrimidines under microwave irradiation [J].
Bessieres, Maxime ;
Roy, Vincent ;
Agrofoglio, Luigi A. .
RSC ADVANCES, 2014, 4 (104) :59747-59749
[4]  
Cahard D, 2004, MINI-REV MED CHEM, V4, P371
[5]   Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340 [J].
Chapman, H ;
Kernan, M ;
Prisbe, E ;
Rohloff, J ;
Sparacino, M ;
Terhorst, T ;
Yu, R .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :621-628
[6]   Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131 [J].
Cihlar, Tomas ;
Ray, Adrian S. ;
Boojamra, Constantine G. ;
Zhang, Lijun ;
Hui, Hon ;
Laflamme, Genevieve ;
Vela, Jennifer E. ;
Grant, Deborah ;
Chen, James ;
Myrick, Florence ;
White, Kirsten L. ;
Gao, Ying ;
Lin, Kuei-Ying ;
Douglas, Janet L. ;
Parkin, Neil T. ;
Carey, Anne ;
Pakdaman, Rowchanak ;
Mackman, Richard L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :655-665
[7]   Acyclic nucleoside phosphonates: Past, present and future - Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: The phosphonate bridge [J].
De Clercq, E. .
BIOCHEMICAL PHARMACOLOGY, 2007, 73 (07) :911-922
[8]   Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy [J].
De Clercq, E ;
Field, HJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (01) :1-11
[9]   Acyclic nucleoside phosphonates: A key class of antiviral drugs [J].
De Clercq, E ;
Holy, A .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (11) :928-940
[10]   A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT [J].
DECLERCQ, E ;
HOLY, A ;
ROSENBERG, I ;
SAKUMA, T ;
BALZARINI, J ;
MAUDGAL, PC .
NATURE, 1986, 323 (6087) :464-467